Skip to Content

Frequently Searched

Supported by

Advancements in Patient-Centered Care

Stay up to date with the latest advancements in oral oncolytics, medically-integrated oncology, and cancer care best practices.

NCODA UPDATES

SORT

Bispecific T-Cell Engagers (BTCEs) Directory

NCODA’s veteran support resources provide oncology care teams with guidance, tools, and strategies to deliver coordinated, patient-centered care for veterans across clinical and community settings.

NCODA Resource Guide

NCODA’s veteran support resources provide oncology care teams with guidance, tools, and strategies to deliver coordinated, patient-centered care for veterans across clinical and community settings.

Protecting Patient-Centered Oncology Care from Harmful Step Edits

Cancer care depends on delivering the right therapy at the right time. NCODA strongly opposes step therapy policies in oncology, as they delay appropriate treatment, increase the risk of avoidable complications and drug waste, and undermine the cost-avoidance benefits achieved through medically integrated oncology care.

PEComa Care Delivery Across the Academic–Community Oncology Continuum

January 13, 2026
Perivascular epithelioid cell tumors (PEComas) are ultra-rare mesenchymal malignancies that present significant diagnostic and treatment challenges across oncology settings. This white paper examines PEComa care delivery across the academic–community oncology continuum, using real-world perspectives from both settings to illustrate how diagnosis, treatment, and long-term management are operationalized in practice.

NCODA 2025 Fall Summit: Championing a Decade of Impact in Medically Integrated Oncology Care

As the 2025 NCODA Fall Summit begins this afternoon in Orlando, we are excited to welcome oncology professionals from across the country for three days of education, collaboration, and innovation—building on ten years of advancing the medically integrated model of care. This year’s Summit theme, “Championing Medically Integrated Oncology: Celebrating a Decade of Impact,” recognizes the progress and the remarkable contributions of our members who continue to elevate oncology care and transform patients’ lives.

NCODA Awards First International Medically Integrated Pharmacy Center of Excellence Accreditation

NCODA, Inc., an internationally recognized organization dedicated to promoting enhanced integrated patient care and quality services, proudly announces that Larivière et Massicotte, Pharmaciennes, Inc., a clinical pharmacy based in Quebec, Canada, has been officially awarded the NCODA Center of Excellence (CoE) Multi-Specialty with Oncology Focus Medically Integrated Pharmacy (MIP) Accreditation via the Canadian Pharmacy Accreditation Services, an NCODA company.

Coming Soon: Important OCE/IVE Updates

OCE and IVE sheets will soon be known as Patient Education Sheets — clearer, more consistent, and still rooted in the expert-backed information you rely on.

Optimizing Subcutaneous Therapy: Key Considerations and Collaborative Opportunities

June 23, 2025
The adoption of subcutaneous (SC) oncology therapies is increasing, offering benefits like shorter clinic visits, improved patient experience, and greater efficiency. However, challenges in administration techniques, equipment use, and workflow integration remain. NCODA’s oncology nursing experts are addressing these gaps through education, best practices, and collaborative partnerships to support consistent, high-quality SC therapy delivery.